Humanin is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Humanin analogs show neuroprotection in Alzheimer's models, synapse preservation, and cognitive improvements in aging mice. Reduced inflammatory markers and improved metabolic healthspan in treated animals. Zero human clinical trials completed. Phase II studies planned. Humanin is not fda-approved. research peptide only.
What Does the Research Say About Humanin?
Humanin analogs show neuroprotection in Alzheimer's models, synapse preservation, and cognitive improvements in aging mice. Reduced inflammatory markers and improved metabolic healthspan in treated animals. Zero human clinical trials completed. Phase II studies planned.
Humanin (Humanin mitochondrial-derived peptide) is a Mitochondrial-derived peptide, cytoprotective factor. Research interest has focused on its potential effects on neuroprotection, Alzheimer's disease mitigation, cognitive preservation, anti-aging, metabolic health, mitochondrial restoration.
What Is the Evidence for Humanin's Mechanism?
Stabilizes mitochondrial function and prevents mitochondrial dysfunction-induced neuronal death. Activates survival signaling through IGF-1R and MAPK pathways. Reduces oxidative stress and exerts anti-inflammatory effects by reducing pro-inflammatory cytokine production. Specifically protects against Aβ42-induced neuronal damage in Alzheimer's models.
These pathways have been identified through in vitro studies, animal models, and where available, human trials.
Are There Human Clinical Trials for Humanin?
Humanin analogs show neuroprotection in Alzheimer's models, synapse preservation, and cognitive improvements in aging mice. Reduced inflammatory markers and improved metabolic healthspan in treated animals. Zero human clinical trials completed. Phase II studies planned.
The gap between preclinical promise and clinical validation remains the biggest challenge in peptide research. However, Humanin has shown encouraging results.
What Does the Safety Research Show?
No significant side effects in preclinical studies. Human safety data completely absent. Potential for antibody formation with chronic use.
Humanin is not fda-approved. research peptide only.
What Makes Humanin Unique in Research?
One of only two known mitochondrial-encoded peptides with therapeutic potential (alongside MOTS-C), representing a completely new class of endogenous anti-aging factors that decline with age.
This differentiator is important because it means Humanin fills a role that other compounds in its class may not fully replicate.
Bottom Line on Humanin Research
The evidence base for Humanin is growing. Key research areas include neuroprotection, Alzheimer's disease mitigation, cognitive preservation, anti-aging, metabolic health, mitochondrial restoration.
Stay current with PubMed searches for Humanin for the latest publications.
Complete Guide
Humanin: The Mitochondrial Peptide
Related Reading
- Humanin Dosage Guide
- Humanin Benefits
- Humanin Side Effects
- Humanin Stacking Guide
- Humanin Cycle Guide
- MOTS-C Complete Guide
Calculate Your Humanin Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Humanin.
Open Calculator →Research-Grade Sourcing
If you're going to research Humanin, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Humanin?
Humanin (Humanin mitochondrial-derived peptide) is a Mitochondrial-derived peptide, cytoprotective factor. Endogenous 24-amino acid peptide encoded within mitochondrial DNA, released under stress conditions as a survival signal. It is researched for neuroprotection, Alzheimer's disease mitigation, cognitive preservation, anti-aging, metabolic health, mitochondrial restoration.
What is the recommended Humanin dosage?
Common dosages: 2.5 mg/kg (animal studies); human dosing not established administered twice daily in animal protocols via subcutaneous injection (proposed for humans). Cycle length: human protocol undefined; chronic dosing in animal models. Half-life: ~30 minutes in mice; >4 hours in rats. Use our peptide calculator for exact reconstitution math.
What are the side effects of Humanin?
No significant side effects in preclinical studies. Human safety data completely absent. Potential for antibody formation with chronic use.
Is Humanin safe?
Humanin has shown a preliminary safety profile in research. Not FDA-approved. Research peptide only. All research should follow appropriate safety protocols.